World‑Renowned Dalhousie Bioethicist and Battery Pioneer Win Prestigious Killam Prize
By Andrew Riley and Caitlyn MacDonald,
Dal News
| 03. 15. 2022
Françoise Baylis, photo by XhenetaM,
CC BY-SA 4.0, via Wikimedia Commons
Two of Dalhousie’s leading researchers are being honoured with the $100,000 Killam Prize, winning two of the five prestigious awards granted annually by the Killam Trusts.
On Tuesday morning, the Canada Council for the Arts announced Françoise Baylis and Jeff Dahn as 2022 recipients of the honour. Offered to Canadian scholars who have distinguished themselves through sustained distinction and impact in their fields, the Killam Prize is considered the top national award of research excellence.
“It is a historic achievement for our university to have two Killam Prize winners in one year. Drs. Baylis and Dahn are known internationally for advancing knowledge in their fields – areas that promise to shape the way we live in the future,” says Deep Saini, Dalhousie’s president and vice-chancellor.
Drs. Baylis and Dahn are only the fifth and sixth Dalhousie faculty members to receive a Killam Prize since the awards were created in 1981. Biology’s Brian Hall (2005), Philosophy’s Susan Sherwin (2006), Chemistry's Axel Becke (2016), and Medicine's Ford Doolittle (2017)...
Related Articles
By Tory Shepherd, The Guardian | 07.17.2026
Over eight years, Ethan and his wife went through nine rounds of IVF in Melbourne.
They travelled to Spain for two more, without success.
“I thought maybe the universe had decided we’re not supposed to have kids,” says Ethan, who...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
